2022
DOI: 10.1016/j.cpcardiol.2021.100941
|View full text |Cite
|
Sign up to set email alerts
|

Primary Graft Dysfunction after Heart Transplantation – Unravelling the Enigma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 199 publications
0
8
0
2
Order By: Relevance
“…We chose to focus on these two parameters as they are the single most influential parameters on transplant survival. 26 It is worth clarifying that this was not a controlled trial, therefore it is possible that there could be confounders.…”
Section: Articlesmentioning
confidence: 99%
See 1 more Smart Citation
“…We chose to focus on these two parameters as they are the single most influential parameters on transplant survival. 26 It is worth clarifying that this was not a controlled trial, therefore it is possible that there could be confounders.…”
Section: Articlesmentioning
confidence: 99%
“…Further to this, the sample distribution was not equal between CS and ESMP groups, with CS having significantly more cases. It also would have been beneficial to analyse the pre-transplantation use of MCS in recipients, as this is also an important factor in influencing post-transplant survival, 26 but unfortunately these data were not available. Further to this, gathering data from this number of centres is a sensitive task and some centres were unable to provide a full characterisation of their DBD data.…”
Section: Articlesmentioning
confidence: 99%
“…A number of risk factors associated with the donor, the recipient, organ transport and implantation procedure are linked to PGD (Fig. 2) [10 ▪ ].…”
Section: Risk Factors and Predicting Primary Graft Dysfunctionmentioning
confidence: 99%
“…Die Prävalenz der CAV steigt von 8 % nach 1 Jahr auf über 30 % nach 5 Jahren und ist mit einem schlechten Überleben assoziiert. 81,82 Der Einsatz der ECP begann bereits Anfang der 90er Jahre und im Jahr 1998 wurde die erste multizentrische, randomisierte Studie vorgestellt, in der 60 Patienten entweder eine immunsuppressive Tripeltherapie oder zusätzlich eine ECP erhielten. In der ECP-Gruppe wurden signifikant weniger Abstoßungsepisoden beobachtet, jedoch keine Verbesserung der Überlebensrate.…”
Section: Herztransplantationunclassified
“…Eine wichtige Ursache ist die Transplantatvaskulopathie (TVD), die auch den Langzeiterfolg einschränkt. Die Prävalenz der CAV steigt von 8 % nach 1 Jahr auf über 30 % nach 5 Jahren und ist mit einem schlechten Überleben assoziiert 81,82 …”
Section: Organtransplantationunclassified